295 related articles for article (PubMed ID: 21505799)
1. Lafora progressive myoclonus epilepsy: NHLRC1 mutations affect glycogen metabolism.
Couarch P; Vernia S; Gourfinkel-An I; Lesca G; Gataullina S; Fedirko E; Trouillard O; Depienne C; Dulac O; Steschenko D; Leguern E; Sanz P; Baulac S
J Mol Med (Berl); 2011 Sep; 89(9):915-25. PubMed ID: 21505799
[TBL] [Abstract][Full Text] [Related]
2. Lafora progressive myoclonus epilepsy: recent insights into cell degeneration.
Spuch C; Ortolano S; Navarro C
Recent Pat Endocr Metab Immune Drug Discov; 2012 May; 6(2):99-107. PubMed ID: 22369717
[TBL] [Abstract][Full Text] [Related]
3. Laforin, the dual-phosphatase responsible for Lafora disease, interacts with R5 (PTG), a regulatory subunit of protein phosphatase-1 that enhances glycogen accumulation.
Fernández-Sánchez ME; Criado-García O; Heath KE; García-Fojeda B; Medraño-Fernández I; Gomez-Garre P; Sanz P; Serratosa JM; Rodríguez de Córdoba S
Hum Mol Genet; 2003 Dec; 12(23):3161-71. PubMed ID: 14532330
[TBL] [Abstract][Full Text] [Related]
4. Laforin is required for the functional activation of malin in endoplasmic reticulum stress resistance in neuronal cells.
Zeng L; Wang Y; Baba O; Zheng P; Liu Y; Liu Y
FEBS J; 2012 Jul; 279(14):2467-78. PubMed ID: 22578008
[TBL] [Abstract][Full Text] [Related]
5. Genetic depletion of the malin E3 ubiquitin ligase in mice leads to lafora bodies and the accumulation of insoluble laforin.
DePaoli-Roach AA; Tagliabracci VS; Segvich DM; Meyer CM; Irimia JM; Roach PJ
J Biol Chem; 2010 Aug; 285(33):25372-81. PubMed ID: 20538597
[TBL] [Abstract][Full Text] [Related]
6. Lafora disease in the Indian population: EPM2A and NHLRC1 gene mutations and their impact on subcellular localization of laforin and malin.
Singh S; Satishchandra P; Shankar SK; Ganesh S
Hum Mutat; 2008 Jun; 29(6):E1-12. PubMed ID: 18311786
[TBL] [Abstract][Full Text] [Related]
7. Deciphering the role of malin in the lafora progressive myoclonus epilepsy.
Romá-Mateo C; Sanz P; Gentry MS
IUBMB Life; 2012 Oct; 64(10):801-8. PubMed ID: 22815132
[TBL] [Abstract][Full Text] [Related]
8. Advances in lafora progressive myoclonus epilepsy.
Delgado-Escueta AV
Curr Neurol Neurosci Rep; 2007 Sep; 7(5):428-33. PubMed ID: 17764634
[TBL] [Abstract][Full Text] [Related]
9. Interdependence of laforin and malin proteins for their stability and functions could underlie the molecular basis of locus heterogeneity in Lafora disease.
Mittal S; Upadhyay M; Singh PK; Parihar R; Ganesh S
J Biosci; 2015 Dec; 40(5):863-71. PubMed ID: 26648032
[TBL] [Abstract][Full Text] [Related]
10. Modulation of functional properties of laforin phosphatase by alternative splicing reveals a novel mechanism for the EPM2A gene in Lafora progressive myoclonus epilepsy.
Dubey D; Ganesh S
Hum Mol Genet; 2008 Oct; 17(19):3010-20. PubMed ID: 18617530
[TBL] [Abstract][Full Text] [Related]
11. Malin decreases glycogen accumulation by promoting the degradation of protein targeting to glycogen (PTG).
Worby CA; Gentry MS; Dixon JE
J Biol Chem; 2008 Feb; 283(7):4069-76. PubMed ID: 18070875
[TBL] [Abstract][Full Text] [Related]
12. Laforin-malin complex degrades polyglucosan bodies in concert with glycogen debranching enzyme and brain isoform glycogen phosphorylase.
Liu Y; Zeng L; Ma K; Baba O; Zheng P; Liu Y; Wang Y
Mol Neurobiol; 2014 Apr; 49(2):645-57. PubMed ID: 24068615
[TBL] [Abstract][Full Text] [Related]
13. Laforin targets malin to glycogen in Lafora progressive myoclonus epilepsy.
Mitra S; Chen B; Wang P; Chown EE; Dear M; Guisso DR; Mariam U; Wu J; Gumusgoz E; Minassian BA
Dis Model Mech; 2023 Jan; 16(1):. PubMed ID: 36511140
[TBL] [Abstract][Full Text] [Related]
14. Mutations in NHLRC1 cause progressive myoclonus epilepsy.
Chan EM; Young EJ; Ianzano L; Munteanu I; Zhao X; Christopoulos CC; Avanzini G; Elia M; Ackerley CA; Jovic NJ; Bohlega S; Andermann E; Rouleau GA; Delgado-Escueta AV; Minassian BA; Scherer SW
Nat Genet; 2003 Oct; 35(2):125-7. PubMed ID: 12958597
[TBL] [Abstract][Full Text] [Related]
15. Impaired malin expression and interaction with partner proteins in Lafora disease.
Skurat AV; Segvich DM; Contreras CJ; Hu YC; Hurley TD; DePaoli-Roach AA; Roach PJ
J Biol Chem; 2024 May; 300(5):107271. PubMed ID: 38588813
[TBL] [Abstract][Full Text] [Related]
16. Regulation of glycogen synthesis by the laforin-malin complex is modulated by the AMP-activated protein kinase pathway.
Solaz-Fuster MC; Gimeno-Alcañiz JV; Ros S; Fernandez-Sanchez ME; Garcia-Fojeda B; Criado Garcia O; Vilchez D; Dominguez J; Garcia-Rocha M; Sanchez-Piris M; Aguado C; Knecht E; Serratosa J; Guinovart JJ; Sanz P; Rodriguez de Córdoba S
Hum Mol Genet; 2008 Mar; 17(5):667-78. PubMed ID: 18029386
[TBL] [Abstract][Full Text] [Related]
17. Increased laforin and laforin binding to glycogen underlie Lafora body formation in malin-deficient Lafora disease.
Tiberia E; Turnbull J; Wang T; Ruggieri A; Zhao XC; Pencea N; Israelian J; Wang Y; Ackerley CA; Wang P; Liu Y; Minassian BA
J Biol Chem; 2012 Jul; 287(30):25650-9. PubMed ID: 22669944
[TBL] [Abstract][Full Text] [Related]
18. Lafora disease proteins laforin and malin negatively regulate the HIPK2-p53 cell death pathway.
Upadhyay M; Gupta S; Bhadauriya P; Ganesh S
Biochem Biophys Res Commun; 2015 Aug; 464(1):106-11. PubMed ID: 26102034
[TBL] [Abstract][Full Text] [Related]
19. Increased endoplasmic reticulum stress and decreased proteasomal function in lafora disease models lacking the phosphatase laforin.
Vernia S; Rubio T; Heredia M; Rodríguez de Córdoba S; Sanz P
PLoS One; 2009 Jun; 4(6):e5907. PubMed ID: 19529779
[TBL] [Abstract][Full Text] [Related]
20. Glycogen synthase downregulation rescues the amylopectinosis of murine RBCK1 deficiency.
Nitschke S; Sullivan MA; Mitra S; Marchioni CR; Lee JPY; Smith BH; Ahonen S; Wu J; Chown EE; Wang P; Petković S; Zhao X; DiGiovanni LF; Perri AM; Israelian L; Grossman TR; Kordasiewicz H; Vilaplana F; Iwai K; Nitschke F; Minassian BA
Brain; 2022 Jul; 145(7):2361-2377. PubMed ID: 35084461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
